Condition

Hepatitis c

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions3

Lead sponsors shown3

Clinical trials

3 shown

Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral InfectionsNCT04363411 · 2018-10-25

COMPLETED

Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in BordeauxNCT03290755 · 2017-11-08

COMPLETED

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected AdultsNCT01472354 · 2010-10-01

COMPLETED

Common interventions

finger prick screening for BBV infections and questionnaires by outreaching methodologyOTHER1 Leap-c group interventionBEHAVIORAL1 semi-directed interviewsBEHAVIORAL1

Leading sponsors

Hasselt University 1 University Hospital, Bordeaux 1 University of Massachusetts, Worcester 1

Trial status mix

COMPLETED3

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.